TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress June 6, 1980